| Evaluation of commercial kits for purification of circulating free DNA |
15 |
| SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq) |
11 |
| Circulating cell-free DNA for non-invasive cancer management |
11 |
| Comparison of 4 commercial kits for the extraction of circulating DNA from plasma |
11 |
| Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker |
10 |
| Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing |
9 |
| Somatic mutation panels: Time to clear their names |
9 |
| Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer |
9 |
| Novel rearrangements involving the RET gene in papillary thyroid carcinoma |
8 |
| ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review |
8 |
| Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells |
7 |
| Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group |
7 |
| Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases |
6 |
| Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers |
6 |
| Long noncoding RNA CCAT1 polymorphisms are associated with the risk of colorectal cancer |
6 |
| A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival |
6 |
| Molecular evaluation of BRAF V600 mutation and its association with clinicopathological characteristics: First findings from Indian malignant melanoma patients |
5 |
| Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data |
5 |
| Primary aneurysmal bone cyst with a novel SPARC-USP6 translocation identified by next-generation sequencing |
5 |
| Mutation analysis of therapy-related myeloid neoplasms |
5 |
| Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia |
5 |
| Dysregulated expression of repetitive DNA in ER+/HER2-breast cancer |
5 |
| Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing |
5 |
| FANCM, RAD CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer |
4 |
| Association of transcriptional levels of folate-mediated one-carbon metabolism-related genes in cancer cell lines with drug treatment response |
4 |
| Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group |
4 |
| Decoding colorectal cancer epigenomics |
4 |
| Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations |
4 |
| Single nucleotide polymorphism rs10889677 in miRNAs Let-7e and Let-7f binding site of IL23R gene is a strong colorectal cancer determinant: Report and meta-analysis |
4 |
| Differentially expressed LncRNAs as potential prognostic biomarkers for glioblastoma |
4 |
| SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia |
4 |
| ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis |
4 |
| Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinoma |
4 |
| Characterization of novel, large duplications in the MSH2 gene of three unrelated Lynch syndrome patients |
3 |
| Familial Esophageal Squamous Cell Carcinoma with damaging rare/germline mutations in KCNJ12/KCNJ18 and GPRIN2 genes |
3 |
| Potential of epigenetic events in human thyroid cancer |
3 |
| STK11 gene analysis reveals a significant number of splice mutations in Chinese PJS patients |
3 |
| Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature |
3 |
| The clinical and prognostic significance of FIS SPI PDCD7 and Ang2 expression levels in acute myeloid leukemia |
3 |
| Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center |
3 |
| Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia |
3 |
| Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms |
3 |
| Expression deregulation of DNA repair pathway genes in gastric cancer |
3 |
| p53 major hotspot variants are associated with poorer prognostic features in hereditary cancer patients |
3 |
| A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data |
3 |
| BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival |
3 |
| The role of E-cadherin and Runx3 in Helicobacter Pylori - Associated gastric carcinoma is achieved through regulating P21waf and P27 expression |
3 |
| Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) |
3 |
| ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma |
2 |
| Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation |
2 |
